Crexont
RxNorm concept 2690260, brand name (bn).
- RxCUI
- 2690260
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2690260 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- carbidopa 35 MG / levodopa 140 MG [Crexont] (SBDC, ingredient of)
- Crexont Oral Product (SBDG, ingredient of)
- Crexont Pill (SBDG, ingredient of)
- carbidopa / levodopa Extended Release Oral Capsule [Crexont] (SBDF, ingredient of)
- carbidopa 35 MG / levodopa 140 MG Extended Release Oral Capsule [Crexont] (SBD, ingredient of)
- carbidopa 52.5 MG / levodopa 210 MG [Crexont] (SBDC, ingredient of)
- carbidopa 52.5 MG / levodopa 210 MG Extended Release Oral Capsule [Crexont] (SBD, ingredient of)
- carbidopa 70 MG / levodopa 280 MG [Crexont] (SBDC, ingredient of)
- carbidopa 70 MG / levodopa 280 MG Extended Release Oral Capsule [Crexont] (SBD, ingredient of)
- carbidopa 87.5 MG / levodopa 350 MG [Crexont] (SBDC, ingredient of)
- carbidopa 87.5 MG / levodopa 350 MG Extended Release Oral Capsule [Crexont] (SBD, ingredient of)
- carbidopa (IN, tradename of)
- levodopa (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2690260 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2690260 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2690260. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.